To determine the level of tumor-infiltrating immune cells, we examined CD3+ T cells and F4/80+ macrophages in tumors from KPC, Palb2-KPC, Brca1-KPC, and Brca2-KPC animals. The gene discussed is BRCA2; the disease is neoplasm.